Table 1

baseline characteristics i-scan multicentre study

Baseline characteristics, n=107N%
Age (median; range 23–85 years)67
Gender (female:male)32:7530:70
Performance status
 ECOG 04340
 ECOG 15047
 ECOG 21211
 ECOG 311
Preprocedure evaluation (available imaging prior to bronchoscopy
 CT thorax92%
Localisation tumour target lesion
Clinical TNM stage (v7) prior to bronchoscopy
Bronchoscopy details
Sedation for bronchoscopy
 Midazolam (mean dose: 4.72±0.4 mg, range 1.3–9.0 mg)2523
 General anaesthesia2826
Study procedure time (min)11±0.8
Use of fluoroscopy2927
 Haemorrhage needing topical agents54.7
 Severe haemorrhage00
  • ECOG, Eastern Cooperative Oncology Group; LLL, left lower lobe; LUL, left upper lobe; ML, middle lobe;  PET, positron emission tomography; RLL, right lower lobe; RUL, right upper lobe; TNM, tumour, node, metastases.